Friday 6 November 2026 Export MEDP’s income statement to Excel — free account

Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue: +8.50%
EPS: +24.6%
Free cash flow: −16.6%

Quarter to September 2026, against a year earlier

645.16 10.18 +1.60%

Follow MEDP

Alert me

Market cap: $17.8B
P/E: 34.6×
Fwd P/E: 35.8×
Dividend yield: —
F-score: 8/9
Altman Z: 8.04
Beneish M: −2.92
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Medpace Holdings, Inc. 8-K filed Jun 4, 2026

Period ended Jun 1, 2026 · Filed Jun 4, 2026 · accepted 4:06 PM ET · Document on sec.gov · Filing index

5.02 Departure or appointment of directors or officers

Red flags

Officer departure Jun 4, 2026
Medpace Holdings, Inc. reported the departure of an officer or director

8-K filed Jun 4, 2026 · The filing · sec.gov